SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-015590
Filing Date
2019-08-14
Accepted
2019-08-13 18:42:12
Documents
45
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0619_wizepharma.htm 10-Q 499319
2 CERTIFICATION f10q0619ex31-1_wize.htm EX-31.1 7590
3 CERTIFICATION f10q0619ex31-2_wize.htm EX-31.2 7584
4 CERTIFICATION f10q0619ex32-1_wize.htm EX-32.1 4132
5 CERTIFICATION f10q0619ex32-2_wize.htm EX-32.2 4026
  Complete submission text file 0001213900-19-015590.txt   2774471

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE wizp-20190630.xml EX-101.INS 499943
7 XBRL SCHEMA FILE wizp-20190630.xsd EX-101.SCH 34561
8 XBRL CALCULATION FILE wizp-20190630_cal.xml EX-101.CAL 31867
9 XBRL DEFINITION FILE wizp-20190630_def.xml EX-101.DEF 100360
10 XBRL LABEL FILE wizp-20190630_lab.xml EX-101.LAB 239854
11 XBRL PRESENTATION FILE wizp-20190630_pre.xml EX-101.PRE 173255
Mailing Address 24 HANAGAR ST HOD HASHARON L3 4527713
Business Address 24 HANAGAR ST HOD HASHARON L3 4527713 972 472 260 0536
Wize Pharma, Inc. (Filer) CIK: 0001218683 (see all company filings)

IRS No.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52545 | Film No.: 191022263
SIC: 2834 Pharmaceutical Preparations